ISN Journal summaries on vitamin D for minimal change disease and AKI caused by West Nile virus
Kidney International® A randomized controlled non-inferiority trial examined lower dose prednisolone and activated vitamin D in adult minimal change podocytopathy This study tested whether lower-dose prednisolone combined with activated vitamin D could match standard high-dose prednisolone for remission in adults with minimal change disease while reducing steroid toxicity. Although non-inferiority was not formally established, the lower-dose regimen...